Cargando…
Exploiting glycan topography for computational design of Env glycoprotein antigenicity
Mounting evidence suggests that glycans, rather than merely serving as a “shield”, contribute critically to antigenicity of the HIV envelope (Env) glycoprotein, representing critical antigenic determinants for many broadly neutralizing antibodies (bNAbs). While many studies have focused on defining...
Autores principales: | Yu, Wen-Han, Zhao, Peng, Draghi, Monia, Arevalo, Claudia, Karsten, Christina B., Suscovich, Todd J., Gunn, Bronwyn, Streeck, Hendrik, Brass, Abraham L., Tiemeyer, Michael, Seaman, Michael, Mascola, John R., Wells, Lance, Lauffenburger, Douglas A., Alter, Galit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931682/ https://www.ncbi.nlm.nih.gov/pubmed/29677181 http://dx.doi.org/10.1371/journal.pcbi.1006093 |
Ejemplares similares
-
Antiviral protection by antibodies targeting the glycan cap of Ebola virus glycoprotein requires activation of the complement system
por: Bukreyev, Alexander, et al.
Publicado: (2023) -
Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea Pigs
por: Bricault, Christine A., et al.
Publicado: (2018) -
Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap
por: Ilinykh, Philipp A., et al.
Publicado: (2018) -
A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation()
por: Fischinger, Stephanie, et al.
Publicado: (2019) -
Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates
por: Gunn, Bronwyn M., et al.
Publicado: (2023)